Mechanistic Studies of HIV-exposed Seronegative Individuals
HIV 血清阴性个体的机制研究
基本信息
- 批准号:8503631
- 负责人:
- 金额:$ 36.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAllelesAnti-Retroviral AgentsAntigen-Presenting CellsAnusAreaBehaviorBiologicalBiological FactorsCCR5 geneCD4 Positive T LymphocytesCellular ImmunityCohort StudiesDataDefensinsDeveloped CountriesDevelopmentEducational workshopEnrollmentEpidemicEquilibriumExhibitsExposure toFatigueGeneral PopulationGeneticGenetic PolymorphismGenetic StatusGenomeGenotypeHIVHIV-1HLA AntigensHealthImmuneImmune responseImmune systemIncidenceIndividualInfectionInfection preventionIntegration Host FactorsLifeLinkLymphocyte ActivationMetabolicMinorMucous MembraneNatural HistoryNatural ImmunityPathway interactionsPattern recognition receptorPersonsPharmaceutical PreparationsPharmacologic SubstancePhenotypePredispositionPrevention approachProductionPropertyRecruitment ActivityRelative (related person)ResistanceResourcesRiskSignal TransductionSingle Nucleotide PolymorphismSiteSolutionsStimulusSurfaceSurveysUnited States National Institutes of HealthVaccinationVaccine DesignViralVirusVulnerable Populationsadaptive immunitybasecohortcopingdesignhigh riskinterestmenmen&aposs grouppandemic diseaserectalresistance mechanismsuccesstheoriestransmission processviral resistance
项目摘要
DESCRIPTION (provided by applicant): As detailed in the "Request For Applications" to which this proposal responds, the mechanisms of resistance of some individuals to HIV-1 infection (highly exposed seronegative, HESN) remain poorly understood. Major questions regarding this phenomenon were raised at an NIH workshop on this topic that serves as the basis for this RFA, including: 1) What is different in HESN versus those who get infected? 2) What is the immune response in HESN and is it just a marker of exposure or a correlate of protection? 3) What are the HESN host factors that help HESN resist infection? This proposal addresses these issues by exploring the overarching hypothesis that innate immune reactivity is a key determinant of CD4+ T lymphocyte activation at mucosal surfaces, and therefore a key determinant of susceptibility to HIV-1 infection of an individual. HESN may be different in terms of innate immune reactivity, which would be a key difference in the immune response of these persons compared to the general population, and not necessarily HIV-1-specific. The host factors determining this difference likely would be genetic, which will be explored by whole genome single nucleotide polymorphism examination in a complementary study. We will pursue this hypothesis by examining a unique cohort of men in the Multicenter AIDS Cohort Study who had extremely high-risk sexual exposures in the early- to mid-1980s, yet remained uninfected. The susceptibility and reactivity of their mucosal innate immune system will be assessed using HIV-1 infection and examining the effects of defined stimuli of pattern recognition receptors. We will focus on their site of sexual exposure, the rectal mucosa. Specifically, we propose: ¿ To determine innate immune signals important for HIV-1 replication in gut mucosa and quantitate the ability of gut mucosa from HESN to support HIV-1 replication ¿ To assess the innate immune responsiveness of HESN gut mucosa to different stimuli ¿ To examine the phenotypes of antigen-presenting cells in the gut mucosa of HESN
描述(由申请人提供):正如本提案回应的“申请申请”中详细说明的那样,一些人对艾滋病毒-1感染(高度暴露的血清阴性,HESN)的抵抗机制仍然知之甚少。关于这一现象的主要问题是在作为RFA基础的NIH研讨会上提出的,包括:1)HESN与那些感染的人有什么不同?2)HESN的免疫反应是什么,它只是暴露的标志还是保护的相关性?3)HESN的宿主因素是帮助HESN抵抗感染的?这一建议通过探索一个重要的假设来解决这些问题,即先天免疫反应性是粘膜表面CD4+T淋巴细胞激活的关键决定因素,因此也是个人感染HIV-1的关键决定因素。HESN在先天免疫反应性方面可能不同,这将是这些人与普通人群相比免疫反应的关键差异,而不一定是HIV-1特异性的。决定这种差异的宿主因素可能是遗传因素,这将在一项补充研究中通过全基因组单核苷酸多态检查来探索。我们将通过检查多中心艾滋病队列研究中的一组独特的男性来进一步研究这一假设,这些男性在20世纪80年代初至中期有过极高风险的性行为,但仍未感染。他们的粘膜天然免疫系统的敏感性和反应性将通过HIV-1感染和检查模式识别受体的特定刺激的影响来评估。我们将重点关注他们的性行为暴露部位,直肠粘膜。具体地说,我们建议:?确定肠粘膜中对HIV-1复制至关重要的先天免疫信号,并量化HESN肠粘膜支持HIV-1复制的能力?评估HESN肠粘膜对不同刺激的先天免疫反应性?检查HESN肠粘膜中抗原提呈细胞的表型
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter A Anton其他文献
The Other Compartment: Challenges and Progress in Rectal Microbicide Development
- DOI:
10.1186/1742-4690-2-s1-s89 - 发表时间:
2005-12-08 - 期刊:
- 影响因子:3.900
- 作者:
Peter A Anton - 通讯作者:
Peter A Anton
Peter A Anton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter A Anton', 18)}}的其他基金
Topical Microbicides: Targeted Intracellular Delivery
局部杀菌剂:靶向细胞内递送
- 批准号:
8810224 - 财政年份:2014
- 资助金额:
$ 36.17万 - 项目类别:
Topical Microbicides: Targeted Intracellular Delivery
局部杀菌剂:靶向细胞内递送
- 批准号:
8711813 - 财政年份:2014
- 资助金额:
$ 36.17万 - 项目类别:
Exploratory human trials of rectal microbicides
直肠杀菌剂的探索性人体试验
- 批准号:
7979345 - 财政年份:2009
- 资助金额:
$ 36.17万 - 项目类别:
Regulatory compliance and human subjects safety
法规遵从性和人体受试者安全
- 批准号:
7979340 - 财政年份:2009
- 资助金额:
$ 36.17万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.17万 - 项目类别:
Research Grant